Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Mar;91(3):819–828. doi: 10.1172/JCI116302

Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.

S E Dagogo-Jack 1, S Craft 1, P E Cryer 1
PMCID: PMC288033  PMID: 8450063

Abstract

We hypothesize that in patients with insulin-dependent diabetes mellitus (IDDM), recent antecedent iatrogenic hypoglycemia is a major cause of hypoglycemia-associated autonomic failure, a disorder distinct from classical diabetic autonomic neuropathy (CDAN), and that hypoglycemia-associated autonomic failure, by reducing both symptoms of and defense against developing hypoglycemia, results in recurrent iatrogenic hypoglycemia, thus creating a vicious cycle. We used the hyperinsulinemic (12.0 pmol.kg-1.min-1) stepped hypoglycemic clamp technique to assess autonomic and symptomatic responses to hypoglycemia and the insulin infusion test (4.0 pmol.kg-1.min-1) to assess defense against hypoglycemia on mornings before and after clamped afternoon hypoglycemia (approximately 2.8 mmol/liter) and hyperglycemia (approximately 11.1 mmol/liter) in patients with IDDM. Compared with nondiabetic subjects, IDDM with or without CDAN exhibited reduced epinephrine (P = 0.0222 and 0.0040) and pancreatic polypeptide (P = 0.0083 and 0.0056) responses to hypoglycemia. After afternoon hypoglycemia, lower plasma glucose concentrations were required to elicit autonomic and symptomatic responses during morning hypoglycemic clamps in patients without CDAN. At the 2.8 mmol/liter step, mean (+/- SE) epinephrine levels were 1,160 +/- 270 and 2,040 +/- 270 pmol/liter (P = 0.0060), pancreatic and total symptom scores were 22 +/- 3 and 41 +/- 7 (P = 0.0475) after afternoon hypoglycemia and hyperglycemia, respectively. During morning insulin infusion tests after afternoon hypoglycemia, nadir plasma glucose concentrations were 2.6 +/- 0.2 mmol/liter compared with 3.3 +/- 0.3 mmol/liter (P < 0.001) at the corresponding time points after afternoon hyperglycemia. Thus, we conclude: (a) elevated glycemic thresholds for autonomic responses to hypoglycemia are a feature of IDDM per se, not classical diabetic autonomic neuropathy; and (b) a single episode of afternoon hypoglycemia results in both elevated glycemic thresholds for autonomic and symptomatic responses to hypoglycemia and impaired physiological defense against hypoglycemia the next morning in IDDM.

Full text

PDF
819

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amiel S. A., Pottinger R. C., Archibald H. R., Chusney G., Cunnah D. T., Prior P. F., Gale E. A. Effect of antecedent glucose control on cerebral function during hypoglycemia. Diabetes Care. 1991 Feb;14(2):109–118. doi: 10.2337/diacare.14.2.109. [DOI] [PubMed] [Google Scholar]
  2. Amiel S. A., Sherwin R. S., Simonson D. C., Tamborlane W. V. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes. 1988 Jul;37(7):901–907. doi: 10.2337/diab.37.7.901. [DOI] [PubMed] [Google Scholar]
  3. Amiel S. A., Tamborlane W. V., Simonson D. C., Sherwin R. S. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med. 1987 May 28;316(22):1376–1383. doi: 10.1056/NEJM198705283162205. [DOI] [PubMed] [Google Scholar]
  4. Bolli G. B., De Feo P., De Cosmo S., Perriello G., Ventura M. M., Benedetti M. M., Santeusanio F., Gerich J. E., Brunetti P. A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes. 1984 Aug;33(8):732–737. doi: 10.2337/diab.33.8.732. [DOI] [PubMed] [Google Scholar]
  5. Bolli G., de Feo P., Compagnucci P., Cartechini M. G., Angeletti G., Santeusanio F., Brunetti P., Gerich J. E. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes. 1983 Feb;32(2):134–141. doi: 10.2337/diab.32.2.134. [DOI] [PubMed] [Google Scholar]
  6. Boyle P. J., Schwartz N. S., Shah S. D., Clutter W. E., Cryer P. E. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med. 1988 Jun 9;318(23):1487–1492. doi: 10.1056/NEJM198806093182302. [DOI] [PubMed] [Google Scholar]
  7. Cahill G. F., Jr, Herrera M. G., Morgan A. P., Soeldner J. S., Steinke J., Levy P. L., Reichard G. A., Jr, Kipnis D. M. Hormone-fuel interrelationships during fasting. J Clin Invest. 1966 Nov;45(11):1751–1769. doi: 10.1172/JCI105481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clarke W. L., Gonder-Frederick L. A., Richards F. E., Cryer P. E. Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control. Diabetes. 1991 Jun;40(6):680–685. doi: 10.2337/diab.40.6.680. [DOI] [PubMed] [Google Scholar]
  9. Cryer P. E. Decreased sympathochromaffin activity in IDDM. Diabetes. 1989 Apr;38(4):405–409. doi: 10.2337/diab.38.4.405. [DOI] [PubMed] [Google Scholar]
  10. Cryer P. E. Does central nervous system adaptation to antecedent glycemia occur in patients with insulin-dependent diabetes mellitus? Ann Intern Med. 1985 Aug;103(2):284–286. doi: 10.7326/0003-4819-103-2-284. [DOI] [PubMed] [Google Scholar]
  11. Cryer P. E. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes. 1992 Mar;41(3):255–260. doi: 10.2337/diab.41.3.255. [DOI] [PubMed] [Google Scholar]
  12. Davis M. R., Mellman M., Shamoon H. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes. 1992 Oct;41(10):1335–1340. doi: 10.2337/diab.41.10.1335. [DOI] [PubMed] [Google Scholar]
  13. Davis M. R., Shamoon H. Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab. 1991 Nov;73(5):995–1001. doi: 10.1210/jcem-73-5-995. [DOI] [PubMed] [Google Scholar]
  14. Farmer R. W., Pierce C. E. Plasma cortisol determination: radioimmunoassay and competitive protein binding compared. Clin Chem. 1974 Apr;20(4):411–414. [PubMed] [Google Scholar]
  15. Fukuda M., Tanaka A., Tahara Y., Ikegami H., Yamamoto Y., Kumahara Y., Shima K. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control. Diabetes. 1988 Jan;37(1):81–88. doi: 10.2337/diab.37.1.81. [DOI] [PubMed] [Google Scholar]
  16. Genovely H., Pfeifer M. A. RR-variation: the autonomic test of choice in diabetes. Diabetes Metab Rev. 1988 May;4(3):255–271. doi: 10.1002/dmr.5610040305. [DOI] [PubMed] [Google Scholar]
  17. Gerich J. E., Langlois M., Noacco C., Karam J. H., Forsham P. H. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science. 1973 Oct 12;182(4108):171–173. doi: 10.1126/science.182.4108.171. [DOI] [PubMed] [Google Scholar]
  18. Gingerich R. L., Lacy P. E., Chance R. E., Johnson M. G. Regional pancreatic concentration and in-vitro secretion of canine pancreatic polypeptide, insulin, and glucagon. Diabetes. 1978 Feb;27(2):96–101. doi: 10.2337/diab.27.2.96. [DOI] [PubMed] [Google Scholar]
  19. Grimaldi A., Bosquet F., Davidoff P., Digy J. P., Sachon C., Landault C., Thervet F., Zoghbi F., Legrand J. C. Unawareness of hypoglycemia by insulin-dependent diabetics. Horm Metab Res. 1990 Feb;22(2):90–95. doi: 10.1055/s-2007-1004858. [DOI] [PubMed] [Google Scholar]
  20. Gulan M., Perlman K., Sole M., Albisser A. M., Zinman B. Counterregulatory hormone responses preserved after long-term intravenous insulin infusion compared to continuous subcutaneous insulin infusion. Diabetes. 1988 May;37(5):526–531. doi: 10.2337/diab.37.5.526. [DOI] [PubMed] [Google Scholar]
  21. Heller S. R., Cryer P. E. Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans. Am J Physiol. 1991 Jul;261(1 Pt 1):E41–E48. doi: 10.1152/ajpendo.1991.261.1.E41. [DOI] [PubMed] [Google Scholar]
  22. Heller S. R., Cryer P. E. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes. 1991 Feb;40(2):223–226. doi: 10.2337/diab.40.2.223. [DOI] [PubMed] [Google Scholar]
  23. Heller S. R., Macdonald I. A., Herbert M., Tattersall R. B. Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet. 1987 Aug 15;2(8555):359–363. doi: 10.1016/s0140-6736(87)92382-8. [DOI] [PubMed] [Google Scholar]
  24. Hepburn D. A., Patrick A. W., Brash H. M., Thomson I., Frier B. M. Hypoglycaemia unawareness in type 1 diabetes: a lower plasma glucose is required to stimulate sympatho-adrenal activation. Diabet Med. 1991 Dec;8(10):934–945. doi: 10.1111/j.1464-5491.1991.tb01533.x. [DOI] [PubMed] [Google Scholar]
  25. Hepburn D. A., Patrick A. W., Eadington D. W., Ewing D. J., Frier B. M. Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med. 1990 Sep-Oct;7(8):711–717. doi: 10.1111/j.1464-5491.1990.tb01475.x. [DOI] [PubMed] [Google Scholar]
  26. Hilsted J., Madsbad S., Krarup T., Sestoft L., Christensen N. J., Tronier B., Galbo H. Hormonal, metabolic, and cardiovascular responses to hypoglycemia in diabetic autonomic neuropathy. Diabetes. 1981 Aug;30(8):626–633. doi: 10.2337/diab.30.8.626. [DOI] [PubMed] [Google Scholar]
  27. Hirsch B. R., Shamoon H. Defective epinephrine and growth hormone responses in type I diabetes are stimulus specific. Diabetes. 1987 Jan;36(1):20–26. doi: 10.2337/diab.36.1.20. [DOI] [PubMed] [Google Scholar]
  28. Hirsch I. B., Boyle P. J., Craft S., Cryer P. E. Higher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDM. Diabetes. 1991 Sep;40(9):1177–1186. doi: 10.2337/diab.40.9.1177. [DOI] [PubMed] [Google Scholar]
  29. Hosaka K., Kikuchi T., Mitsuhida N., Kawaguchi A. A new colorimetric method for the determination of free fatty acids with acyl-CoA synthetase and acyl-CoA oxidase. J Biochem. 1981 Jun;89(6):1799–1803. doi: 10.1093/oxfordjournals.jbchem.a133380. [DOI] [PubMed] [Google Scholar]
  30. Kuzuya H., Blix P. M., Horwitz D. L., Steiner D. F., Rubenstein A. H. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes. 1977 Jan;26(1):22–29. doi: 10.2337/diab.26.1.22. [DOI] [PubMed] [Google Scholar]
  31. LOWRY O. H., PASSONNEAU J. V., HASSELBERGER F. X., SCHULZ D. W. EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN. J Biol Chem. 1964 Jan;239:18–30. [PubMed] [Google Scholar]
  32. Leveston S. A., Shah S. D., Cryer P. E. Cholinergic stimulation of norepinephrine release in man. Evidence of a sympathetic postganglionic axonal lesion in diabetic adrenergic neuropathy. J Clin Invest. 1979 Aug;64(2):374–380. doi: 10.1172/JCI109471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Matthews D. M., Martyn C. N., Riemersma R. A., Clarke B. F., Ewing D. J. Noradrenaline response to edrophonium (Tensilon) and its relation to other autonomic tests in diabetic subjects. Diabetes Res. 1987 Dec;6(4):175–180. [PubMed] [Google Scholar]
  34. McCall A. L., Fixman L. B., Fleming N., Tornheim K., Chick W., Ruderman N. B. Chronic hypoglycemia increases brain glucose transport. Am J Physiol. 1986 Oct;251(4 Pt 1):E442–E447. doi: 10.1152/ajpendo.1986.251.4.E442. [DOI] [PubMed] [Google Scholar]
  35. Mitrakou A., Ryan C., Veneman T., Mokan M., Jenssen T., Kiss I., Durrant J., Cryer P., Gerich J. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol. 1991 Jan;260(1 Pt 1):E67–E74. doi: 10.1152/ajpendo.1991.260.1.E67. [DOI] [PubMed] [Google Scholar]
  36. Pelligrino D. A., Segil L. J., Albrecht R. F. Brain glucose utilization and transport and cortical function in chronic vs. acute hypoglycemia. Am J Physiol. 1990 Nov;259(5 Pt 1):E729–E735. doi: 10.1152/ajpendo.1990.259.5.E729. [DOI] [PubMed] [Google Scholar]
  37. Pinter J. K., Hayashi J. A., Watson J. A. Enzymic assay of glycerol, dihydroxyacetone, and glyceraldehyde. Arch Biochem Biophys. 1967 Aug;121(2):404–414. doi: 10.1016/0003-9861(67)90094-x. [DOI] [PubMed] [Google Scholar]
  38. Popp D. A., Shah S. D., Cryer P. E. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. J Clin Invest. 1982 Feb;69(2):315–326. doi: 10.1172/JCI110455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pramming S., Thorsteinsson B., Bendtson I., Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med. 1991 Apr;8(3):217–222. doi: 10.1111/j.1464-5491.1991.tb01575.x. [DOI] [PubMed] [Google Scholar]
  40. Ryder R. E., Owens D. R., Hayes T. M., Ghatei M. A., Bloom S. R. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. BMJ. 1990 Oct 6;301(6755):783–787. doi: 10.1136/bmj.301.6755.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. SCHALCH D. S., PARKER M. L. A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA. Nature. 1964 Sep 12;203:1141–1142. doi: 10.1038/2031141a0. [DOI] [PubMed] [Google Scholar]
  42. Schwartz N. S., Clutter W. E., Shah S. D., Cryer P. E. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest. 1987 Mar;79(3):777–781. doi: 10.1172/JCI112884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Shah S. D., Clutter W. E., Cryer P. E. External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. J Lab Clin Med. 1985 Dec;106(6):624–629. [PubMed] [Google Scholar]
  44. Shah S. D., Tse T. F., Clutter W. E., Cryer P. E. The human sympathochromaffin system. Am J Physiol. 1984 Sep;247(3 Pt 1):E380–E384. doi: 10.1152/ajpendo.1984.247.3.E380. [DOI] [PubMed] [Google Scholar]
  45. Sjöbom N. C., Adamson U., Lin P. E. The prevalence of impaired glucose counter-regulation during an insulin-infusion test in insulin-treated diabetic patients prone to severe hypoglycaemia. Diabetologia. 1989 Nov;32(11):818–825. doi: 10.1007/BF00264914. [DOI] [PubMed] [Google Scholar]
  46. White N. H., Skor D. A., Cryer P. E., Levandoski L. A., Bier D. M., Santiago J. V. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 1983 Mar 3;308(9):485–491. doi: 10.1056/NEJM198303033080903. [DOI] [PubMed] [Google Scholar]
  47. Widom B., Simonson D. C. Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann Intern Med. 1990 Jun 15;112(12):904–912. doi: 10.7326/0003-4819-112-12-904. [DOI] [PubMed] [Google Scholar]
  48. Widom B., Simonson D. C. Intermittent hypoglycemia impairs glucose counterregulation. Diabetes. 1992 Dec;41(12):1597–1602. doi: 10.2337/diab.41.12.1597. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES